argenx announces efficacy and expanded safety data from Phase 1 trial of ARGX-111

Wednesday, June 1, 2016 1 min read

Key Takeaway: argenx announces efficacy and expanded safety data from Phase 1 trial of ARGX-111

Full Press Release Details

argenx announces efficacy and expanded safety data from Phase 1 trial of ARGX-111.